ArticleHemaSphere2023

Obinutuzumab Can Be Administered as a 90-minute Short Duration Infusion in Patients With Previously Untreated Follicular Lymphoma: GAZELLE End of Induction Analysis.

Miguel A Canales et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.